David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.36% |
| 2 | Technology | 13.15% |
| 3 | Financials | 9.51% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Atossa Therapeutics
ATOS
$26.3M
| $1.47M | ﹤0.01% |
117,822
-34,154
| -22% | -$496K |
|
3127
Renasant Corp
RNST
$3.77B
| $1.47M | ﹤0.01% |
47,019
-27,728
| -37% | -$902K |
|
3128
Latham Group
SWIM
$821M
| $1.47M | ﹤0.01% |
409,204
+197,595
| +93% | +$1.13M |
|
3129
PBF Energy
PBF
$8.13B
| $1.47M | ﹤0.01% |
41,657
-12,552
| -23% | -$398K |
|
3130
e.l.f. Beauty
ELF
$6.26B
| $1.46M | ﹤0.01% |
38,873
+10,902
| +39% | +$394K |
|
|
ZIMV
3131
DELISTED
ZimVie
ZIMV
| $1.46M | ﹤0.01% |
148,121
-3,989
| -3% | -$64.3K |
|
3132
Middlesex Water
MSEX
$1.09B
| $1.46M | ﹤0.01% |
18,856
+14,451
| +328% | +$1.29M |
|
3133
Cenovus Energy
CVE
$58.5B
| $1.45M | ﹤0.01% |
94,191
-2,817,522
| -97% | -$50.1M |
|
3134
PUT
Constellation Brands
STZ
$22.4B
| $1.45M | ﹤0.01% |
6,300
-1,500
| -19% | -$366K |
|
|
BAND
3135
PUT
Bandwidth Inc
BAND
$1.67B
| $1.45M | ﹤0.01% |
121,400
+60,000
| +98% | +$986K |
|
3136
CALL
On Holding
ONON
$9.68B
| $1.45M | ﹤0.01% |
90,000
| – | – |
|
3137
PUT
Quaker Houghton
KWR
$2.83B
| $1.44M | ﹤0.01% |
10,000
| – | – |
|
|
AAWW
3138
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $1.44M | ﹤0.01% |
15,109
-32,180
| -68% | -$2.84M |
|
|
SABRP
3139
DELISTED
Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock
SABRP
| $1.44M | ﹤0.01% |
20,100
| – | – |
|
3140
Kiniksa Pharmaceuticals
KNSA
$6.23B
| $1.44M | ﹤0.01% |
112,171
+69,243
| +161% | +$789K |
|
3141
PUT
Autohome
ATHM
$2.6B
| $1.44M | ﹤0.01% |
50,000
| – | – |
|
|
PPHP
3142
DELISTED
PHP Ventures Acquisition Corp. Class A Common Stock
PPHP
| $1.44M | ﹤0.01% |
142,312
| – | – |
|
|
SP
3143
DELISTED
SP Plus Corporation
SP
| $1.43M | ﹤0.01% |
45,801
-7,011
| -13% | -$232K |
|
3144
Telkom Indonesia
TLK
$14.3B
| $1.43M | ﹤0.01% |
49,637
-34,760
| -41% | -$1.02M |
|
|
EXK
3145
Endeavour Silver
EXK
$3.35B
| $1.43M | ﹤0.01% |
473,717
+85,322
| +22% | +$270K |
|
3146
Reynolds Consumer Products
REYN
$5.1B
| $1.43M | ﹤0.01% |
55,013
-136,115
| -71% | -$3.84M |
|
3147
Tronox
TROX
$877M
| $1.43M | ﹤0.01% |
116,815
-93,055
| -44% | -$1.38M |
|
3148
CALL
Beam Therapeutics
BEAM
$3.15B
| $1.43M | ﹤0.01% |
+30,000
| New | +$1.71M |
|
3149
CALL
Group 1 Automotive
GPI
$3.12B
| $1.43M | ﹤0.01% |
+10,000
| New | +$1.72M |
|
3150
CALL
eBay
EBAY
$45.5B
| $1.43M | ﹤0.01% |
+38,800
| New | +$1.73M |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $7.97B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.